Freakonomics Radio
In blue cities across the country, unions and politicians want to ban self-driving cars. In this episode from the Search Engine podcast, PJ Vogt visits Boston to sort the facts from the propaganda. (Part two of a two-part series.)
- SOURCES:
- Carl Richardson, ADA coordinator for the Massachusetts State House, president of the Guide Dog Users of Massachusetts.
- Gabriela Coletta Zapata, Boston City councilor from District 1.
- Julia Mejia, Boston City councilor at-large.
- Timothy B. Lee, author of Understanding AI newsletter.
- RESOURCES:
- “Waymo Hits a Rough Patch in Washington, DC,” by Aarian Marshall (WIRED, 2026).
- “New York drops plan to legalize robotaxis in setback for Waymo,” by Andrew J. Hawkins (The Verge, 2026).
- “Waymo’s next five cities are all in red states,” by Timothy B. Lee and Kai Williams (Understanding AI, 2025).
- “What Waymo could mean for Bostonians with disabilities: independence at their fingertips,” by Carl Richardson (Boston Globe, 2025).
- “Planning, Development and Transportation on July 24, 2025,” (Boston City Council, 2025).
- “Ride-Hailing Drivers in Massachusetts Win Right to Unionize,” by Eli Tan (The New York Times, 2024).
- “East Coast Longshore Workers May Soon Strike,” by Joe Demanuelle-Hall (Jacobin, 2024).
- EXTRAS:
- “The Fascinatingly Mundane Secrets of the World’s Most Exclusive Nightclub,” by Freakonomics Radio (2024).
- Search Engine, podcast by PJ Vogt.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

440. Does Advertising Actually Work? (Part 1: TV)
Companies around the world spend more than half-a-trillion dollars each year on ads. The ad industry swears by its efficacy — but a massive new study tells a different story.
439. Please Get Your Noise Out of My Ears
The modern world overwhelms us with sounds we didn’t ask for, like car alarms and cell-phone “halfalogues.” What does all this noise cost us in terms of productivity, health, and basic sanity?
438. How to Succeed by Being Authentic (Hint: Carefully)
John Mackey, the C.E.O. of Whole Foods, has learned the perils of speaking his mind. But he still says what he thinks about everything from “conscious leadership” to the behavioral roots of the obesity epidemic.…
Why the Left Had to Steal the Right’s Dark-Money Playbook
The sociologist Sudhir Venkatesh spent years studying crack dealers, sex workers, and the offspring of billionaires. Then he wandered into an even stranger world: social media. He spent the past five years at Facebook and…
437. Many Businesses Thought They Were Insured for a Pandemic. They Weren’t.
A fine reading of most policies for “business interruption” reveals that viral outbreaks aren’t covered. Some legislators are demanding that insurance firms pay up anyway. Is it time to rethink insurance entirely?
436. Forget Everything You Know About Your Dog
As beloved and familiar as they are, we rarely stop to consider life from the dog’s point of view. That stops now. In this latest installment of the Freakonomics Radio Book Club, we discuss Inside…
435. Why Are Cities (Still) So Expensive?
It isn’t just supply and demand. We look at the complicated history and skewed incentives that make “affordable housing” more punch line than reality in cities from New York and San Francisco to Flint, Michigan…
434. Is New York City Over?
The pandemic has hit America’s biggest city particularly hard. Amidst a deep fiscal hole, rising homicides, and a flight to the suburbs, some people think the city is heading back to the bad old 1970s.…
“Don’t Neglect the Thing That Makes You Weird” | People I (Mostly) Admire: Ken Jennings
It was only in his late twenties that America’s favorite brainiac began to seriously embrace his love of trivia. Now he holds the “Greatest of All Time” title on Jeopardy! Steve Levitt digs into how…
433. How Are Psychedelics and Other Party Drugs Changing Psychiatry?
Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides,…
